SMTL ID : 5eyc.1

Crystal structure of c-Met in complex with naphthyridinone inhibitor 5

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.80 Å

Oligo State

monomer

Ligands

1 x 5SZ: 6-[(1~{R})-1-[8-fluoranyl-6-(3-methyl-1,2-oxazol-5-yl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]-1,6-naphthyridin-5-one(Non-covalent)

5SZ.1: 19 residues within 4Å: Chain A: I.37, G.38, V.45, A.61, L.93, L.110, P.111, Y.112, M.113, D.117, N.120, R.161, N.162, C.163, M.164, A.174, D.175, A.179, Y.183 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:I.37, A:I.37, A:A.61, A:L.110, A:D.117 Hydrogen bonds: A:M.113, A:D.175 pi-Stacking: A:Y.183

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Boezio, A.A. et al., Discovery of (R)-6-(1-(8-Fluoro-6-(1-methyl-1H-pyrazol-4-yl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl)ethyl)-3-(2-methoxyethoxy)-1,6-naphthyridin-5(6H)-one (AMG 337), a Potent and Selective Inhibitor of MET with High Unbound Target Coverage and Robust In Vivo Antitumor Activity. J.Med.Chem. (2016)

Release Date

2016-02-10

Peptides

Hepatocyte growth factor receptor: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Hepatocyte growth factor receptor

Related Entries With Identical Sequence